Annexon Bio Brings On Rheos Exec Sanjay Keswani as Chief Medical Officer
Sanjay Keswani has left the president and CEO post at Rheos Medicines to become chief medical officer of Annexon Biosciences. Keswani’s experience also includes positions at Roche, Bristol-Myers Squibb (NYSE: BMY), and Eli Lilly (NYSE: LLY). In other moves, South San Francisco-based Annexon named Jennifer Lew chief financial officer and Lesley Stolz chief business officer. Annexon is developing drugs to treat autoimmune and neurodegenerative diseases.
More from EXOME
Trending on Xconomy
Underwriters and Partners
Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX
Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes
Investment in Wisconsin startups reaches new record total
Tax credits help tech innovators attract capital, fuel growth
Wisconsin Economic Development Corporation